JANET MENDEL: Open Payments
NPI 1457495459 · MOORESTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,289 in 64 payments from 14 companies in 2025. Trend: 2023 $1,464 · 2024 $1,488 · 2025 $1,289
Food & beverage: $1,104Education: $185
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 7 | $243 |
| Janssen Biotech, Inc. | 7 | $207 |
| ABBVIE INC. | 13 | $175 |
| LEO Pharma Inc. | 10 | $162 |
| Amgen Inc. | 5 | $93 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| GENZYME CORPORATION | 3 | $64 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
Products named: NEMLUVIO, TREMFYA, DUPIXENT, ADBRY, SKYRIZI, Otezla, RINVOQ, ILUMYA.
Industry payments across NJ — which companies pay providers there.
